Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will gather and compare data about the effectiveness and safety of two different
treatments for extensive Small Cell Lung Cancer (SCLC) in patients who have not received
previous chemotherapy. One treatment will use an investigational drug in combination with an
FDA approved chemotherapy. The other treatment will use a combination of two FDA approved
chemotherapy drugs.